NEWS 02.20.2026 Chugai Pharmaceutical : Launches “ELEVIDYS” as Japan’s First Regenerative Medical Product for Duchenne Muscular Dystrophy – marketscreener.com
NEWS 02.20.2026 Japan’s health ministry panel endorses 2 iPS cell-derived products | NHK WORLD-JAPAN News – nhk.or.jp